Kris Nelson currently serves as a Senior Remodulin Cardiopulmonary Device Specialist and PH-ILD Cardiopulmonary Specialist at United Therapeutics Corporation, a position held since November 2019. Prior to this, Kris accumulated nearly three decades of experience at Glaxo SmithKline, where roles included Senior Executive Health System Account Manager, focusing on contracting and business analysis for large Integrated Health Systems, and various senior account management positions responsible for promoting patient outcomes and optimizing healthcare strategies. Kris has a proven track record of establishing relationships with key stakeholders, utilizing data to enhance synergies, mentoring new specialists, and demonstrating excellence in sales performance, which garnered numerous awards. Educational qualifications include a Bachelor of Arts degree in Biology from St. Olaf College.